ECOR electroCore, Inc.

Nasdaq electrocore.com


$ 6.00 $ 0.00 (0 %)    

Thursday, 13-Nov-2025 07:00:00 EST
QQQ $ 619.91 $ 0.00 (0 %)
DIA $ 482.12 $ 0.00 (0 %)
SPY $ 682.00 $ 0.00 (0 %)
TLT $ 89.93 $ 0.00 (0 %)
GLD $ 388.92 $ 0.00 (0 %)
$ 6.06
$ 6.30
$ 5.70 x 5
$ 6.00 x 8
-- - --
$ 4.16 - $ 19.49
84,677
na
48.46M
$ 0.91
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-05-2025 09-30-2025 10-Q
2 08-06-2025 06-30-2025 10-Q
3 05-07-2025 03-31-2025 10-Q
4 03-12-2025 12-31-2024 10-K
5 11-13-2024 09-30-2024 10-Q
6 08-07-2024 06-30-2024 10-Q
7 05-08-2024 03-31-2024 10-Q
8 03-13-2024 12-31-2023 10-K
9 11-08-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-03-2023 03-31-2023 10-Q
12 03-08-2023 12-31-2022 10-K
13 11-03-2022 09-30-2022 10-Q
14 08-04-2022 06-30-2022 10-Q
15 05-05-2022 03-31-2022 10-Q
16 03-10-2022 12-31-2021 10-K
17 11-04-2021 09-30-2021 10-Q
18 08-05-2021 06-30-2021 10-Q
19 05-06-2021 03-31-2021 10-Q
20 03-11-2021 12-31-2020 10-K
21 11-12-2020 09-30-2020 10-Q
22 08-13-2020 06-30-2020 10-Q
23 05-15-2020 03-31-2020 10-Q
24 03-30-2020 12-31-2019 10-K
25 11-14-2019 09-30-2019 10-Q
26 08-14-2019 06-30-2019 10-Q
27 05-15-2019 03-31-2019 10-Q
28 03-28-2019 12-31-2018 10-K
29 11-14-2018 09-30-2018 10-Q
30 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 electrocore-granted-patent--us-12469610-b2-for-systems-and-methods-for-treating-blood-clots-with-nerve-stimulation

https://ppubs.uspto.gov/api/pdf/downloadPdf/12469610?requestToken=eyJzdWIiOiIzZTQ5MWI5NS0wZjI4LTQwYjQtOGIyNS05ZmVhNTU3MDU1MjYiL...

 electrocore-sees-fy2025-sales-31500m-32500m-vs-30749m-est

electroCore (NASDAQ:ECOR) sees FY2025 sales of $31.500 million-$32.500 million vs $30.749 million analyst estimate.

 electrocore-q3-eps-040-inline-sales-8700m-beat-7843m-estimate

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.40) per share which met the analyst consensus estimate. This is a 29...

 electrocore-announces-its-gammacore-sapphire-non-invasive-vagus-nerve-stimulation-device-has-been-included-in-long-term-reimbursement-policy-by-belgiums-national-institute-for-health-and-disability-insurance

electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that gammaCor...

 electrocore-q2-eps-044-misses-031-estimate-sales-7381m-beat-7219m-estimate

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.31)...

 electrocore-q1-eps-047-misses-035-estimate-sales-672m-miss-768m-estimate

electroCore (NASDAQ:ECOR) reported quarterly losses of $(0.47) per share which missed the analyst consensus estimate of $(0.35)...

 hc-wainwright--co-reiterates-buy-on-electrocore-maintains-25-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates electroCore (NASDAQ:ECOR) with a Buy and maintains $25 pri...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION